nodes	percent_of_prediction	percent_of_DWPC	metapath
Valproic Acid—UGT1A4—Tamoxifen—pancreatic cancer	0.16	0.253	CbGbCtD
Valproic Acid—UGT1A9—Irinotecan—pancreatic cancer	0.0495	0.0783	CbGbCtD
Valproic Acid—UGT2B7—Epirubicin—pancreatic cancer	0.0481	0.0762	CbGbCtD
Valproic Acid—SLC22A7—Fluorouracil—pancreatic cancer	0.0406	0.0644	CbGbCtD
Valproic Acid—CYP2A6—Tamoxifen—pancreatic cancer	0.0313	0.0496	CbGbCtD
Valproic Acid—SLC22A7—Docetaxel—pancreatic cancer	0.031	0.0492	CbGbCtD
Valproic Acid—CYP2A6—Fluorouracil—pancreatic cancer	0.0231	0.0365	CbGbCtD
Valproic Acid—CYP2B6—Tamoxifen—pancreatic cancer	0.0204	0.0323	CbGbCtD
Valproic Acid—CYP3A5—Tamoxifen—pancreatic cancer	0.0161	0.0254	CbGbCtD
Valproic Acid—CYP2B6—Irinotecan—pancreatic cancer	0.0156	0.0248	CbGbCtD
Valproic Acid—CYP2C8—Tamoxifen—pancreatic cancer	0.0154	0.0245	CbGbCtD
Valproic Acid—CYP1A2—Dacarbazine—pancreatic cancer	0.015	0.0238	CbGbCtD
Valproic Acid—CYP3A5—Erlotinib—pancreatic cancer	0.0137	0.0216	CbGbCtD
Valproic Acid—CYP2C8—Erlotinib—pancreatic cancer	0.0131	0.0208	CbGbCtD
Valproic Acid—CYP2C19—Tamoxifen—pancreatic cancer	0.0129	0.0205	CbGbCtD
Valproic Acid—CYP3A5—Irinotecan—pancreatic cancer	0.0123	0.0195	CbGbCtD
Valproic Acid—CYP1A2—Tamoxifen—pancreatic cancer	0.0119	0.0189	CbGbCtD
Valproic Acid—CYP2C8—Fluorouracil—pancreatic cancer	0.0114	0.018	CbGbCtD
Valproic Acid—CYP2C9—Tamoxifen—pancreatic cancer	0.0108	0.0171	CbGbCtD
Valproic Acid—CYP1A2—Erlotinib—pancreatic cancer	0.0102	0.0161	CbGbCtD
Valproic Acid—CYP3A5—Docetaxel—pancreatic cancer	0.00903	0.0143	CbGbCtD
Valproic Acid—CYP3A5—Sunitinib—pancreatic cancer	0.00899	0.0142	CbGbCtD
Valproic Acid—CYP1A2—Fluorouracil—pancreatic cancer	0.00881	0.0139	CbGbCtD
Valproic Acid—CYP2B6—Doxorubicin—pancreatic cancer	0.00855	0.0135	CbGbCtD
Valproic Acid—CYP2C9—Fluorouracil—pancreatic cancer	0.00793	0.0126	CbGbCtD
Valproic Acid—CYP3A4—Tamoxifen—pancreatic cancer	0.00626	0.00992	CbGbCtD
Valproic Acid—CYP3A4—Erlotinib—pancreatic cancer	0.00532	0.00843	CbGbCtD
Valproic Acid—CYP3A4—Irinotecan—pancreatic cancer	0.00481	0.00761	CbGbCtD
Valproic Acid—UGT2B15—gall bladder—pancreatic cancer	0.00421	0.0828	CbGeAlD
Valproic Acid—CYP3A4—Docetaxel—pancreatic cancer	0.00352	0.00558	CbGbCtD
Valproic Acid—CYP3A4—Sunitinib—pancreatic cancer	0.00351	0.00555	CbGbCtD
Valproic Acid—OGDH—islet of Langerhans—pancreatic cancer	0.00306	0.0602	CbGeAlD
Valproic Acid—UGT2B15—islet of Langerhans—pancreatic cancer	0.00276	0.0543	CbGeAlD
Valproic Acid—HDAC9—islet of Langerhans—pancreatic cancer	0.0027	0.0531	CbGeAlD
Valproic Acid—CYP3A4—Doxorubicin—pancreatic cancer	0.00263	0.00416	CbGbCtD
Valproic Acid—UGT1A10—digestive system—pancreatic cancer	0.0025	0.0492	CbGeAlD
Valproic Acid—UGT1A6—digestive system—pancreatic cancer	0.00233	0.0458	CbGeAlD
Valproic Acid—OGDH—pancreas—pancreatic cancer	0.00215	0.0423	CbGeAlD
Valproic Acid—HDAC2—Topotecan—Irinotecan—pancreatic cancer	0.00205	0.598	CbGdCrCtD
Valproic Acid—UGT1A8—digestive system—pancreatic cancer	0.00198	0.0389	CbGeAlD
Valproic Acid—UGT2B15—pancreas—pancreatic cancer	0.00194	0.0382	CbGeAlD
Valproic Acid—HDAC9—pancreas—pancreatic cancer	0.0019	0.0373	CbGeAlD
Valproic Acid—OGDH—digestive system—pancreatic cancer	0.00184	0.0362	CbGeAlD
Valproic Acid—ABAT—islet of Langerhans—pancreatic cancer	0.00183	0.036	CbGeAlD
Valproic Acid—UGT1A3—digestive system—pancreatic cancer	0.00176	0.0347	CbGeAlD
Valproic Acid—ACADSB—pancreas—pancreatic cancer	0.00171	0.0336	CbGeAlD
Valproic Acid—UGT2B15—digestive system—pancreatic cancer	0.00166	0.0326	CbGeAlD
Valproic Acid—UGT1A4—digestive system—pancreatic cancer	0.0015	0.0295	CbGeAlD
Valproic Acid—ACADSB—digestive system—pancreatic cancer	0.00146	0.0287	CbGeAlD
Valproic Acid—HDAC2—Gefitinib—Erlotinib—pancreatic cancer	0.00138	0.402	CbGdCrCtD
Valproic Acid—HDAC2—islet of Langerhans—pancreatic cancer	0.00138	0.0272	CbGeAlD
Valproic Acid—ABAT—pancreas—pancreatic cancer	0.00129	0.0253	CbGeAlD
Valproic Acid—UGT1A9—digestive system—pancreatic cancer	0.00126	0.0247	CbGeAlD
Valproic Acid—CYP2C18—digestive system—pancreatic cancer	0.0011	0.0216	CbGeAlD
Valproic Acid—UGT2B7—digestive system—pancreatic cancer	0.00101	0.0199	CbGeAlD
Valproic Acid—HDAC2—pancreas—pancreatic cancer	0.00097	0.0191	CbGeAlD
Valproic Acid—SLC22A7—digestive system—pancreatic cancer	0.000963	0.0189	CbGeAlD
Valproic Acid—HDAC2—digestive system—pancreatic cancer	0.000828	0.0163	CbGeAlD
Valproic Acid—SLC16A1—digestive system—pancreatic cancer	0.000736	0.0145	CbGeAlD
Valproic Acid—CYP3A5—islet of Langerhans—pancreatic cancer	0.000612	0.012	CbGeAlD
Valproic Acid—CYP2C19—digestive system—pancreatic cancer	0.000467	0.00918	CbGeAlD
Valproic Acid—CYP3A5—pancreas—pancreatic cancer	0.00043	0.00847	CbGeAlD
Valproic Acid—SLC22A5—digestive system—pancreatic cancer	0.000421	0.00828	CbGeAlD
Valproic Acid—CYP1A2—digestive system—pancreatic cancer	0.000381	0.0075	CbGeAlD
Valproic Acid—CYP3A5—digestive system—pancreatic cancer	0.000368	0.00723	CbGeAlD
Valproic Acid—CYP2B6—digestive system—pancreatic cancer	0.000365	0.00719	CbGeAlD
Valproic Acid—CYP2C9—digestive system—pancreatic cancer	0.000362	0.00712	CbGeAlD
Valproic Acid—PTGS1—digestive system—pancreatic cancer	0.00033	0.0065	CbGeAlD
Valproic Acid—CYP3A4—digestive system—pancreatic cancer	0.000276	0.00543	CbGeAlD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	8.84e-05	0.000434	CcSEcCtD
Valproic Acid—Stomatitis—Epirubicin—pancreatic cancer	8.79e-05	0.000432	CcSEcCtD
Valproic Acid—Conjunctivitis—Epirubicin—pancreatic cancer	8.77e-05	0.00043	CcSEcCtD
Valproic Acid—Urinary tract infection—Epirubicin—pancreatic cancer	8.77e-05	0.00043	CcSEcCtD
Valproic Acid—Dysuria—Doxorubicin—pancreatic cancer	8.75e-05	0.00043	CcSEcCtD
Valproic Acid—Neutropenia—Doxorubicin—pancreatic cancer	8.75e-05	0.00043	CcSEcCtD
Valproic Acid—Hypersensitivity—Fluorouracil—pancreatic cancer	8.71e-05	0.000427	CcSEcCtD
Valproic Acid—Dry mouth—Docetaxel—pancreatic cancer	8.7e-05	0.000427	CcSEcCtD
Valproic Acid—Sweating—Epirubicin—pancreatic cancer	8.65e-05	0.000425	CcSEcCtD
Valproic Acid—Pollakiuria—Doxorubicin—pancreatic cancer	8.65e-05	0.000424	CcSEcCtD
Valproic Acid—Asthenia—Gemcitabine—pancreatic cancer	8.62e-05	0.000423	CcSEcCtD
Valproic Acid—Confusional state—Docetaxel—pancreatic cancer	8.6e-05	0.000422	CcSEcCtD
Valproic Acid—Photosensitivity reaction—Doxorubicin—pancreatic cancer	8.54e-05	0.000419	CcSEcCtD
Valproic Acid—Hepatobiliary disease—Epirubicin—pancreatic cancer	8.53e-05	0.000419	CcSEcCtD
Valproic Acid—Anaphylactic shock—Docetaxel—pancreatic cancer	8.53e-05	0.000419	CcSEcCtD
Valproic Acid—Oedema—Docetaxel—pancreatic cancer	8.53e-05	0.000419	CcSEcCtD
Valproic Acid—Weight increased—Doxorubicin—pancreatic cancer	8.52e-05	0.000418	CcSEcCtD
Valproic Acid—Epistaxis—Epirubicin—pancreatic cancer	8.51e-05	0.000418	CcSEcCtD
Valproic Acid—Pruritus—Gemcitabine—pancreatic cancer	8.5e-05	0.000417	CcSEcCtD
Valproic Acid—Infection—Docetaxel—pancreatic cancer	8.47e-05	0.000416	CcSEcCtD
Valproic Acid—Weight decreased—Doxorubicin—pancreatic cancer	8.47e-05	0.000416	CcSEcCtD
Valproic Acid—Sinusitis—Epirubicin—pancreatic cancer	8.46e-05	0.000415	CcSEcCtD
Valproic Acid—Diarrhoea—Irinotecan—pancreatic cancer	8.44e-05	0.000414	CcSEcCtD
Valproic Acid—Agranulocytosis—Epirubicin—pancreatic cancer	8.42e-05	0.000413	CcSEcCtD
Valproic Acid—Pneumonia—Doxorubicin—pancreatic cancer	8.39e-05	0.000412	CcSEcCtD
Valproic Acid—Nervous system disorder—Docetaxel—pancreatic cancer	8.36e-05	0.000411	CcSEcCtD
Valproic Acid—Pruritus—Fluorouracil—pancreatic cancer	8.36e-05	0.00041	CcSEcCtD
Valproic Acid—Thrombocytopenia—Docetaxel—pancreatic cancer	8.35e-05	0.00041	CcSEcCtD
Valproic Acid—Drowsiness—Doxorubicin—pancreatic cancer	8.35e-05	0.00041	CcSEcCtD
Valproic Acid—Tachycardia—Docetaxel—pancreatic cancer	8.32e-05	0.000409	CcSEcCtD
Valproic Acid—Skin disorder—Docetaxel—pancreatic cancer	8.28e-05	0.000407	CcSEcCtD
Valproic Acid—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	8.27e-05	0.000406	CcSEcCtD
Valproic Acid—Bradycardia—Epirubicin—pancreatic cancer	8.24e-05	0.000405	CcSEcCtD
Valproic Acid—Diarrhoea—Gemcitabine—pancreatic cancer	8.22e-05	0.000404	CcSEcCtD
Valproic Acid—Dizziness—Irinotecan—pancreatic cancer	8.16e-05	0.000401	CcSEcCtD
Valproic Acid—Haemoglobin—Epirubicin—pancreatic cancer	8.14e-05	0.0004	CcSEcCtD
Valproic Acid—Stomatitis—Doxorubicin—pancreatic cancer	8.14e-05	0.000399	CcSEcCtD
Valproic Acid—Anorexia—Docetaxel—pancreatic cancer	8.13e-05	0.000399	CcSEcCtD
Valproic Acid—Rhinitis—Epirubicin—pancreatic cancer	8.12e-05	0.000399	CcSEcCtD
Valproic Acid—Conjunctivitis—Doxorubicin—pancreatic cancer	8.11e-05	0.000398	CcSEcCtD
Valproic Acid—Urinary tract infection—Doxorubicin—pancreatic cancer	8.11e-05	0.000398	CcSEcCtD
Valproic Acid—Haemorrhage—Epirubicin—pancreatic cancer	8.1e-05	0.000398	CcSEcCtD
Valproic Acid—Diarrhoea—Fluorouracil—pancreatic cancer	8.09e-05	0.000397	CcSEcCtD
Valproic Acid—Hypoaesthesia—Epirubicin—pancreatic cancer	8.06e-05	0.000396	CcSEcCtD
Valproic Acid—Pharyngitis—Epirubicin—pancreatic cancer	8.04e-05	0.000395	CcSEcCtD
Valproic Acid—Sweating—Doxorubicin—pancreatic cancer	8e-05	0.000393	CcSEcCtD
Valproic Acid—Urinary tract disorder—Epirubicin—pancreatic cancer	8e-05	0.000393	CcSEcCtD
Valproic Acid—Oedema peripheral—Epirubicin—pancreatic cancer	7.98e-05	0.000392	CcSEcCtD
Valproic Acid—Hypotension—Docetaxel—pancreatic cancer	7.97e-05	0.000391	CcSEcCtD
Valproic Acid—Connective tissue disorder—Epirubicin—pancreatic cancer	7.96e-05	0.000391	CcSEcCtD
Valproic Acid—Urethral disorder—Epirubicin—pancreatic cancer	7.94e-05	0.00039	CcSEcCtD
Valproic Acid—Hepatobiliary disease—Doxorubicin—pancreatic cancer	7.89e-05	0.000387	CcSEcCtD
Valproic Acid—Epistaxis—Doxorubicin—pancreatic cancer	7.87e-05	0.000386	CcSEcCtD
Valproic Acid—Vomiting—Irinotecan—pancreatic cancer	7.84e-05	0.000385	CcSEcCtD
Valproic Acid—Sinusitis—Doxorubicin—pancreatic cancer	7.83e-05	0.000384	CcSEcCtD
Valproic Acid—Dizziness—Fluorouracil—pancreatic cancer	7.81e-05	0.000384	CcSEcCtD
Valproic Acid—Visual impairment—Epirubicin—pancreatic cancer	7.8e-05	0.000383	CcSEcCtD
Valproic Acid—Agranulocytosis—Doxorubicin—pancreatic cancer	7.79e-05	0.000382	CcSEcCtD
Valproic Acid—Rash—Irinotecan—pancreatic cancer	7.78e-05	0.000382	CcSEcCtD
Valproic Acid—Dermatitis—Irinotecan—pancreatic cancer	7.77e-05	0.000382	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	7.77e-05	0.000381	CcSEcCtD
Valproic Acid—Headache—Irinotecan—pancreatic cancer	7.73e-05	0.000379	CcSEcCtD
Valproic Acid—Insomnia—Docetaxel—pancreatic cancer	7.71e-05	0.000379	CcSEcCtD
Valproic Acid—Paraesthesia—Docetaxel—pancreatic cancer	7.66e-05	0.000376	CcSEcCtD
Valproic Acid—Erythema multiforme—Epirubicin—pancreatic cancer	7.66e-05	0.000376	CcSEcCtD
Valproic Acid—Vomiting—Gemcitabine—pancreatic cancer	7.64e-05	0.000375	CcSEcCtD
Valproic Acid—Bradycardia—Doxorubicin—pancreatic cancer	7.63e-05	0.000374	CcSEcCtD
Valproic Acid—Dyspnoea—Docetaxel—pancreatic cancer	7.6e-05	0.000373	CcSEcCtD
Valproic Acid—Somnolence—Docetaxel—pancreatic cancer	7.58e-05	0.000372	CcSEcCtD
Valproic Acid—Rash—Gemcitabine—pancreatic cancer	7.58e-05	0.000372	CcSEcCtD
Valproic Acid—Dermatitis—Gemcitabine—pancreatic cancer	7.57e-05	0.000372	CcSEcCtD
Valproic Acid—Eye disorder—Epirubicin—pancreatic cancer	7.57e-05	0.000371	CcSEcCtD
Valproic Acid—Tinnitus—Epirubicin—pancreatic cancer	7.55e-05	0.000371	CcSEcCtD
Valproic Acid—Haemoglobin—Doxorubicin—pancreatic cancer	7.53e-05	0.00037	CcSEcCtD
Valproic Acid—Headache—Gemcitabine—pancreatic cancer	7.53e-05	0.00037	CcSEcCtD
Valproic Acid—Vomiting—Fluorouracil—pancreatic cancer	7.51e-05	0.000369	CcSEcCtD
Valproic Acid—Rhinitis—Doxorubicin—pancreatic cancer	7.51e-05	0.000369	CcSEcCtD
Valproic Acid—Dyspepsia—Docetaxel—pancreatic cancer	7.51e-05	0.000369	CcSEcCtD
Valproic Acid—Haemorrhage—Doxorubicin—pancreatic cancer	7.49e-05	0.000368	CcSEcCtD
Valproic Acid—Hypoaesthesia—Doxorubicin—pancreatic cancer	7.45e-05	0.000366	CcSEcCtD
Valproic Acid—Rash—Fluorouracil—pancreatic cancer	7.45e-05	0.000366	CcSEcCtD
Valproic Acid—Dermatitis—Fluorouracil—pancreatic cancer	7.44e-05	0.000365	CcSEcCtD
Valproic Acid—Pharyngitis—Doxorubicin—pancreatic cancer	7.44e-05	0.000365	CcSEcCtD
Valproic Acid—Decreased appetite—Docetaxel—pancreatic cancer	7.41e-05	0.000364	CcSEcCtD
Valproic Acid—Headache—Fluorouracil—pancreatic cancer	7.4e-05	0.000363	CcSEcCtD
Valproic Acid—Urinary tract disorder—Doxorubicin—pancreatic cancer	7.4e-05	0.000363	CcSEcCtD
Valproic Acid—Oedema peripheral—Doxorubicin—pancreatic cancer	7.38e-05	0.000362	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Docetaxel—pancreatic cancer	7.36e-05	0.000361	CcSEcCtD
Valproic Acid—Connective tissue disorder—Doxorubicin—pancreatic cancer	7.36e-05	0.000361	CcSEcCtD
Valproic Acid—Fatigue—Docetaxel—pancreatic cancer	7.35e-05	0.000361	CcSEcCtD
Valproic Acid—Angiopathy—Epirubicin—pancreatic cancer	7.35e-05	0.000361	CcSEcCtD
Valproic Acid—Urethral disorder—Doxorubicin—pancreatic cancer	7.34e-05	0.000361	CcSEcCtD
Valproic Acid—Nausea—Irinotecan—pancreatic cancer	7.33e-05	0.00036	CcSEcCtD
Valproic Acid—Immune system disorder—Epirubicin—pancreatic cancer	7.31e-05	0.000359	CcSEcCtD
Valproic Acid—Mediastinal disorder—Epirubicin—pancreatic cancer	7.3e-05	0.000358	CcSEcCtD
Valproic Acid—Pain—Docetaxel—pancreatic cancer	7.29e-05	0.000358	CcSEcCtD
Valproic Acid—Constipation—Docetaxel—pancreatic cancer	7.29e-05	0.000358	CcSEcCtD
Valproic Acid—Chills—Epirubicin—pancreatic cancer	7.27e-05	0.000357	CcSEcCtD
Valproic Acid—Arrhythmia—Epirubicin—pancreatic cancer	7.23e-05	0.000355	CcSEcCtD
Valproic Acid—Visual impairment—Doxorubicin—pancreatic cancer	7.22e-05	0.000354	CcSEcCtD
Valproic Acid—Alopecia—Epirubicin—pancreatic cancer	7.16e-05	0.000351	CcSEcCtD
Valproic Acid—Nausea—Gemcitabine—pancreatic cancer	7.14e-05	0.00035	CcSEcCtD
Valproic Acid—Mental disorder—Epirubicin—pancreatic cancer	7.09e-05	0.000348	CcSEcCtD
Valproic Acid—Erythema multiforme—Doxorubicin—pancreatic cancer	7.08e-05	0.000348	CcSEcCtD
Valproic Acid—Malnutrition—Epirubicin—pancreatic cancer	7.05e-05	0.000346	CcSEcCtD
Valproic Acid—Feeling abnormal—Docetaxel—pancreatic cancer	7.03e-05	0.000345	CcSEcCtD
Valproic Acid—Nausea—Fluorouracil—pancreatic cancer	7.02e-05	0.000345	CcSEcCtD
Valproic Acid—Eye disorder—Doxorubicin—pancreatic cancer	7e-05	0.000344	CcSEcCtD
Valproic Acid—Tinnitus—Doxorubicin—pancreatic cancer	6.99e-05	0.000343	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Docetaxel—pancreatic cancer	6.97e-05	0.000342	CcSEcCtD
Valproic Acid—Flatulence—Epirubicin—pancreatic cancer	6.95e-05	0.000341	CcSEcCtD
Valproic Acid—Tension—Epirubicin—pancreatic cancer	6.92e-05	0.00034	CcSEcCtD
Valproic Acid—Dysgeusia—Epirubicin—pancreatic cancer	6.9e-05	0.000339	CcSEcCtD
Valproic Acid—Nervousness—Epirubicin—pancreatic cancer	6.85e-05	0.000336	CcSEcCtD
Valproic Acid—Back pain—Epirubicin—pancreatic cancer	6.82e-05	0.000335	CcSEcCtD
Valproic Acid—Angiopathy—Doxorubicin—pancreatic cancer	6.8e-05	0.000334	CcSEcCtD
Valproic Acid—Muscle spasms—Epirubicin—pancreatic cancer	6.78e-05	0.000333	CcSEcCtD
Valproic Acid—Immune system disorder—Doxorubicin—pancreatic cancer	6.77e-05	0.000332	CcSEcCtD
Valproic Acid—Mediastinal disorder—Doxorubicin—pancreatic cancer	6.75e-05	0.000331	CcSEcCtD
Valproic Acid—Abdominal pain—Docetaxel—pancreatic cancer	6.74e-05	0.000331	CcSEcCtD
Valproic Acid—Body temperature increased—Docetaxel—pancreatic cancer	6.74e-05	0.000331	CcSEcCtD
Valproic Acid—Chills—Doxorubicin—pancreatic cancer	6.72e-05	0.00033	CcSEcCtD
Valproic Acid—Arrhythmia—Doxorubicin—pancreatic cancer	6.69e-05	0.000329	CcSEcCtD
Valproic Acid—Vision blurred—Epirubicin—pancreatic cancer	6.64e-05	0.000326	CcSEcCtD
Valproic Acid—Alopecia—Doxorubicin—pancreatic cancer	6.62e-05	0.000325	CcSEcCtD
Valproic Acid—Mental disorder—Doxorubicin—pancreatic cancer	6.56e-05	0.000322	CcSEcCtD
Valproic Acid—Ill-defined disorder—Epirubicin—pancreatic cancer	6.54e-05	0.000321	CcSEcCtD
Valproic Acid—Malnutrition—Doxorubicin—pancreatic cancer	6.52e-05	0.00032	CcSEcCtD
Valproic Acid—Anaemia—Epirubicin—pancreatic cancer	6.52e-05	0.00032	CcSEcCtD
Valproic Acid—Agitation—Epirubicin—pancreatic cancer	6.48e-05	0.000318	CcSEcCtD
Valproic Acid—Flatulence—Doxorubicin—pancreatic cancer	6.43e-05	0.000315	CcSEcCtD
Valproic Acid—Tension—Doxorubicin—pancreatic cancer	6.4e-05	0.000314	CcSEcCtD
Valproic Acid—Dysgeusia—Doxorubicin—pancreatic cancer	6.39e-05	0.000314	CcSEcCtD
Valproic Acid—Malaise—Epirubicin—pancreatic cancer	6.36e-05	0.000312	CcSEcCtD
Valproic Acid—Nervousness—Doxorubicin—pancreatic cancer	6.33e-05	0.000311	CcSEcCtD
Valproic Acid—Vertigo—Epirubicin—pancreatic cancer	6.33e-05	0.000311	CcSEcCtD
Valproic Acid—Leukopenia—Epirubicin—pancreatic cancer	6.31e-05	0.00031	CcSEcCtD
Valproic Acid—Back pain—Doxorubicin—pancreatic cancer	6.31e-05	0.00031	CcSEcCtD
Valproic Acid—Hypersensitivity—Docetaxel—pancreatic cancer	6.28e-05	0.000308	CcSEcCtD
Valproic Acid—Muscle spasms—Doxorubicin—pancreatic cancer	6.27e-05	0.000308	CcSEcCtD
Valproic Acid—Palpitations—Epirubicin—pancreatic cancer	6.23e-05	0.000306	CcSEcCtD
Valproic Acid—Cough—Epirubicin—pancreatic cancer	6.15e-05	0.000302	CcSEcCtD
Valproic Acid—Vision blurred—Doxorubicin—pancreatic cancer	6.15e-05	0.000302	CcSEcCtD
Valproic Acid—Asthenia—Docetaxel—pancreatic cancer	6.12e-05	0.0003	CcSEcCtD
Valproic Acid—Hypertension—Epirubicin—pancreatic cancer	6.09e-05	0.000299	CcSEcCtD
Valproic Acid—Ill-defined disorder—Doxorubicin—pancreatic cancer	6.05e-05	0.000297	CcSEcCtD
Valproic Acid—Pruritus—Docetaxel—pancreatic cancer	6.03e-05	0.000296	CcSEcCtD
Valproic Acid—Anaemia—Doxorubicin—pancreatic cancer	6.03e-05	0.000296	CcSEcCtD
Valproic Acid—Chest pain—Epirubicin—pancreatic cancer	6e-05	0.000295	CcSEcCtD
Valproic Acid—Myalgia—Epirubicin—pancreatic cancer	6e-05	0.000295	CcSEcCtD
Valproic Acid—Arthralgia—Epirubicin—pancreatic cancer	6e-05	0.000295	CcSEcCtD
Valproic Acid—Agitation—Doxorubicin—pancreatic cancer	5.99e-05	0.000294	CcSEcCtD
Valproic Acid—Anxiety—Epirubicin—pancreatic cancer	5.98e-05	0.000294	CcSEcCtD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	5.96e-05	0.000293	CcSEcCtD
Valproic Acid—Discomfort—Epirubicin—pancreatic cancer	5.93e-05	0.000291	CcSEcCtD
Valproic Acid—Malaise—Doxorubicin—pancreatic cancer	5.88e-05	0.000289	CcSEcCtD
Valproic Acid—Dry mouth—Epirubicin—pancreatic cancer	5.87e-05	0.000288	CcSEcCtD
Valproic Acid—Vertigo—Doxorubicin—pancreatic cancer	5.86e-05	0.000288	CcSEcCtD
Valproic Acid—Leukopenia—Doxorubicin—pancreatic cancer	5.84e-05	0.000287	CcSEcCtD
Valproic Acid—Diarrhoea—Docetaxel—pancreatic cancer	5.84e-05	0.000286	CcSEcCtD
Valproic Acid—Confusional state—Epirubicin—pancreatic cancer	5.8e-05	0.000285	CcSEcCtD
Valproic Acid—Palpitations—Doxorubicin—pancreatic cancer	5.76e-05	0.000283	CcSEcCtD
Valproic Acid—Oedema—Epirubicin—pancreatic cancer	5.75e-05	0.000282	CcSEcCtD
Valproic Acid—Anaphylactic shock—Epirubicin—pancreatic cancer	5.75e-05	0.000282	CcSEcCtD
Valproic Acid—Infection—Epirubicin—pancreatic cancer	5.72e-05	0.000281	CcSEcCtD
Valproic Acid—Cough—Doxorubicin—pancreatic cancer	5.69e-05	0.000279	CcSEcCtD
Valproic Acid—Nervous system disorder—Epirubicin—pancreatic cancer	5.64e-05	0.000277	CcSEcCtD
Valproic Acid—Dizziness—Docetaxel—pancreatic cancer	5.64e-05	0.000277	CcSEcCtD
Valproic Acid—Thrombocytopenia—Epirubicin—pancreatic cancer	5.63e-05	0.000277	CcSEcCtD
Valproic Acid—Hypertension—Doxorubicin—pancreatic cancer	5.63e-05	0.000276	CcSEcCtD
Valproic Acid—Tachycardia—Epirubicin—pancreatic cancer	5.61e-05	0.000276	CcSEcCtD
Valproic Acid—Skin disorder—Epirubicin—pancreatic cancer	5.59e-05	0.000274	CcSEcCtD
Valproic Acid—Hyperhidrosis—Epirubicin—pancreatic cancer	5.56e-05	0.000273	CcSEcCtD
Valproic Acid—Myalgia—Doxorubicin—pancreatic cancer	5.55e-05	0.000273	CcSEcCtD
Valproic Acid—Arthralgia—Doxorubicin—pancreatic cancer	5.55e-05	0.000273	CcSEcCtD
Valproic Acid—Chest pain—Doxorubicin—pancreatic cancer	5.55e-05	0.000273	CcSEcCtD
Valproic Acid—Anxiety—Doxorubicin—pancreatic cancer	5.53e-05	0.000272	CcSEcCtD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	5.51e-05	0.000271	CcSEcCtD
Valproic Acid—Discomfort—Doxorubicin—pancreatic cancer	5.49e-05	0.000269	CcSEcCtD
Valproic Acid—Anorexia—Epirubicin—pancreatic cancer	5.48e-05	0.000269	CcSEcCtD
Valproic Acid—Dry mouth—Doxorubicin—pancreatic cancer	5.43e-05	0.000267	CcSEcCtD
Valproic Acid—Vomiting—Docetaxel—pancreatic cancer	5.42e-05	0.000266	CcSEcCtD
Valproic Acid—Rash—Docetaxel—pancreatic cancer	5.38e-05	0.000264	CcSEcCtD
Valproic Acid—Hypotension—Epirubicin—pancreatic cancer	5.38e-05	0.000264	CcSEcCtD
Valproic Acid—Dermatitis—Docetaxel—pancreatic cancer	5.37e-05	0.000264	CcSEcCtD
Valproic Acid—Confusional state—Doxorubicin—pancreatic cancer	5.37e-05	0.000263	CcSEcCtD
Valproic Acid—Headache—Docetaxel—pancreatic cancer	5.34e-05	0.000262	CcSEcCtD
Valproic Acid—Oedema—Doxorubicin—pancreatic cancer	5.32e-05	0.000261	CcSEcCtD
Valproic Acid—Anaphylactic shock—Doxorubicin—pancreatic cancer	5.32e-05	0.000261	CcSEcCtD
Valproic Acid—Infection—Doxorubicin—pancreatic cancer	5.29e-05	0.00026	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	5.24e-05	0.000257	CcSEcCtD
Valproic Acid—Nervous system disorder—Doxorubicin—pancreatic cancer	5.22e-05	0.000256	CcSEcCtD
Valproic Acid—Thrombocytopenia—Doxorubicin—pancreatic cancer	5.21e-05	0.000256	CcSEcCtD
Valproic Acid—Insomnia—Epirubicin—pancreatic cancer	5.2e-05	0.000255	CcSEcCtD
Valproic Acid—Tachycardia—Doxorubicin—pancreatic cancer	5.2e-05	0.000255	CcSEcCtD
Valproic Acid—Skin disorder—Doxorubicin—pancreatic cancer	5.17e-05	0.000254	CcSEcCtD
Valproic Acid—Paraesthesia—Epirubicin—pancreatic cancer	5.17e-05	0.000254	CcSEcCtD
Valproic Acid—Hyperhidrosis—Doxorubicin—pancreatic cancer	5.15e-05	0.000253	CcSEcCtD
Valproic Acid—Dyspnoea—Epirubicin—pancreatic cancer	5.13e-05	0.000252	CcSEcCtD
Valproic Acid—Somnolence—Epirubicin—pancreatic cancer	5.11e-05	0.000251	CcSEcCtD
Valproic Acid—Anorexia—Doxorubicin—pancreatic cancer	5.07e-05	0.000249	CcSEcCtD
Valproic Acid—Nausea—Docetaxel—pancreatic cancer	5.07e-05	0.000249	CcSEcCtD
Valproic Acid—Dyspepsia—Epirubicin—pancreatic cancer	5.06e-05	0.000249	CcSEcCtD
Valproic Acid—Decreased appetite—Epirubicin—pancreatic cancer	5e-05	0.000245	CcSEcCtD
Valproic Acid—Hypotension—Doxorubicin—pancreatic cancer	4.97e-05	0.000244	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Epirubicin—pancreatic cancer	4.97e-05	0.000244	CcSEcCtD
Valproic Acid—Fatigue—Epirubicin—pancreatic cancer	4.96e-05	0.000243	CcSEcCtD
Valproic Acid—Pain—Epirubicin—pancreatic cancer	4.92e-05	0.000242	CcSEcCtD
Valproic Acid—Constipation—Epirubicin—pancreatic cancer	4.92e-05	0.000242	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	4.85e-05	0.000238	CcSEcCtD
Valproic Acid—Insomnia—Doxorubicin—pancreatic cancer	4.81e-05	0.000236	CcSEcCtD
Valproic Acid—Paraesthesia—Doxorubicin—pancreatic cancer	4.78e-05	0.000235	CcSEcCtD
Valproic Acid—Dyspnoea—Doxorubicin—pancreatic cancer	4.75e-05	0.000233	CcSEcCtD
Valproic Acid—Feeling abnormal—Epirubicin—pancreatic cancer	4.74e-05	0.000233	CcSEcCtD
Valproic Acid—Somnolence—Doxorubicin—pancreatic cancer	4.73e-05	0.000232	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Epirubicin—pancreatic cancer	4.7e-05	0.000231	CcSEcCtD
Valproic Acid—Dyspepsia—Doxorubicin—pancreatic cancer	4.69e-05	0.00023	CcSEcCtD
Valproic Acid—Decreased appetite—Doxorubicin—pancreatic cancer	4.63e-05	0.000227	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	4.6e-05	0.000226	CcSEcCtD
Valproic Acid—Fatigue—Doxorubicin—pancreatic cancer	4.59e-05	0.000225	CcSEcCtD
Valproic Acid—Urticaria—Epirubicin—pancreatic cancer	4.57e-05	0.000224	CcSEcCtD
Valproic Acid—Pain—Doxorubicin—pancreatic cancer	4.55e-05	0.000223	CcSEcCtD
Valproic Acid—Constipation—Doxorubicin—pancreatic cancer	4.55e-05	0.000223	CcSEcCtD
Valproic Acid—Abdominal pain—Epirubicin—pancreatic cancer	4.55e-05	0.000223	CcSEcCtD
Valproic Acid—Body temperature increased—Epirubicin—pancreatic cancer	4.55e-05	0.000223	CcSEcCtD
Valproic Acid—Feeling abnormal—Doxorubicin—pancreatic cancer	4.39e-05	0.000215	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Doxorubicin—pancreatic cancer	4.35e-05	0.000214	CcSEcCtD
Valproic Acid—Hypersensitivity—Epirubicin—pancreatic cancer	4.24e-05	0.000208	CcSEcCtD
Valproic Acid—Urticaria—Doxorubicin—pancreatic cancer	4.23e-05	0.000208	CcSEcCtD
Valproic Acid—Abdominal pain—Doxorubicin—pancreatic cancer	4.21e-05	0.000207	CcSEcCtD
Valproic Acid—Body temperature increased—Doxorubicin—pancreatic cancer	4.21e-05	0.000207	CcSEcCtD
Valproic Acid—Asthenia—Epirubicin—pancreatic cancer	4.13e-05	0.000203	CcSEcCtD
Valproic Acid—Pruritus—Epirubicin—pancreatic cancer	4.07e-05	0.0002	CcSEcCtD
Valproic Acid—Diarrhoea—Epirubicin—pancreatic cancer	3.94e-05	0.000193	CcSEcCtD
Valproic Acid—Hypersensitivity—Doxorubicin—pancreatic cancer	3.92e-05	0.000193	CcSEcCtD
Valproic Acid—Asthenia—Doxorubicin—pancreatic cancer	3.82e-05	0.000187	CcSEcCtD
Valproic Acid—Dizziness—Epirubicin—pancreatic cancer	3.8e-05	0.000187	CcSEcCtD
Valproic Acid—Pruritus—Doxorubicin—pancreatic cancer	3.77e-05	0.000185	CcSEcCtD
Valproic Acid—Vomiting—Epirubicin—pancreatic cancer	3.66e-05	0.00018	CcSEcCtD
Valproic Acid—Diarrhoea—Doxorubicin—pancreatic cancer	3.64e-05	0.000179	CcSEcCtD
Valproic Acid—Rash—Epirubicin—pancreatic cancer	3.63e-05	0.000178	CcSEcCtD
Valproic Acid—Dermatitis—Epirubicin—pancreatic cancer	3.62e-05	0.000178	CcSEcCtD
Valproic Acid—Headache—Epirubicin—pancreatic cancer	3.6e-05	0.000177	CcSEcCtD
Valproic Acid—Dizziness—Doxorubicin—pancreatic cancer	3.52e-05	0.000173	CcSEcCtD
Valproic Acid—Nausea—Epirubicin—pancreatic cancer	3.42e-05	0.000168	CcSEcCtD
Valproic Acid—Vomiting—Doxorubicin—pancreatic cancer	3.38e-05	0.000166	CcSEcCtD
Valproic Acid—Rash—Doxorubicin—pancreatic cancer	3.36e-05	0.000165	CcSEcCtD
Valproic Acid—Dermatitis—Doxorubicin—pancreatic cancer	3.35e-05	0.000165	CcSEcCtD
Valproic Acid—Headache—Doxorubicin—pancreatic cancer	3.33e-05	0.000164	CcSEcCtD
Valproic Acid—Nausea—Doxorubicin—pancreatic cancer	3.16e-05	0.000155	CcSEcCtD
Valproic Acid—UGT1A3—Metabolism—PIK3CD—pancreatic cancer	9.79e-06	8.84e-05	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—PIK3CG—pancreatic cancer	9.73e-06	8.79e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—ARG2—pancreatic cancer	9.72e-06	8.77e-05	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—PIK3CA—pancreatic cancer	9.71e-06	8.77e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—DPYD—pancreatic cancer	9.68e-06	8.74e-05	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—TP53—pancreatic cancer	9.51e-06	8.59e-05	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—PIK3CG—pancreatic cancer	9.47e-06	8.55e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—NFKBIA—pancreatic cancer	9.43e-06	8.51e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—STK11—pancreatic cancer	9.39e-06	8.48e-05	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—PPARG—pancreatic cancer	9.39e-06	8.48e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—NOTCH1—pancreatic cancer	9.33e-06	8.43e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	9.32e-06	8.42e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—SLC2A2—pancreatic cancer	9.19e-06	8.3e-05	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—PIK3CB—pancreatic cancer	9.15e-06	8.26e-05	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—PPARG—pancreatic cancer	9.14e-06	8.25e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—PIK3CG—pancreatic cancer	9.13e-06	8.24e-05	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—HRAS—pancreatic cancer	9.1e-06	8.22e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	9.09e-06	8.21e-05	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—AKT1—pancreatic cancer	9.07e-06	8.19e-05	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—PTGS2—pancreatic cancer	9.06e-06	8.18e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—EGF—pancreatic cancer	9.02e-06	8.15e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	8.99e-06	8.12e-05	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—PTEN—pancreatic cancer	8.87e-06	8.01e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—CTNNB1—pancreatic cancer	8.86e-06	8e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—GLP1R—pancreatic cancer	8.79e-06	7.93e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	8.78e-06	7.93e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PRSS1—pancreatic cancer	8.65e-06	7.81e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—DPYD—pancreatic cancer	8.64e-06	7.81e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—PTEN—pancreatic cancer	8.63e-06	7.79e-05	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—PIK3CD—pancreatic cancer	8.55e-06	7.72e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—TYMS—pancreatic cancer	8.54e-06	7.71e-05	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—PIK3CB—pancreatic cancer	8.53e-06	7.7e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—APOE—pancreatic cancer	8.52e-06	7.7e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—TYMP—pancreatic cancer	8.49e-06	7.67e-05	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—PTGS2—pancreatic cancer	8.45e-06	7.63e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—CD44—pancreatic cancer	8.41e-06	7.59e-05	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—PIK3CD—pancreatic cancer	8.32e-06	7.51e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—CD44—pancreatic cancer	8.22e-06	7.42e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—SLC2A2—pancreatic cancer	8.2e-06	7.41e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	8.2e-06	7.41e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	8.12e-06	7.33e-05	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—PIK3CA—pancreatic cancer	8.1e-06	7.32e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—TYMS—pancreatic cancer	8.08e-06	7.3e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	8.07e-06	7.29e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—GCG—pancreatic cancer	8.06e-06	7.28e-05	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—AKT1—pancreatic cancer	8.03e-06	7.25e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—PIK3CD—pancreatic cancer	8.02e-06	7.25e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—GLP1R—pancreatic cancer	8.01e-06	7.23e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—SRC—pancreatic cancer	8e-06	7.23e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	7.99e-06	7.22e-05	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—AKT1—pancreatic cancer	7.93e-06	7.16e-05	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—PTEN—pancreatic cancer	7.9e-06	7.14e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—DPYD—pancreatic cancer	7.88e-06	7.12e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—GCG—pancreatic cancer	7.88e-06	7.11e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	7.83e-06	7.07e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—MYC—pancreatic cancer	7.73e-06	6.98e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—STAT3—pancreatic cancer	7.72e-06	6.97e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—NRAS—pancreatic cancer	7.7e-06	6.95e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PIK3CG—pancreatic cancer	7.69e-06	6.95e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—STK11—pancreatic cancer	7.58e-06	6.84e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ARG2—pancreatic cancer	7.5e-06	6.77e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—SLC2A2—pancreatic cancer	7.48e-06	6.75e-05	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—PIK3CB—pancreatic cancer	7.46e-06	6.73e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PPARG—pancreatic cancer	7.42e-06	6.7e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—STK11—pancreatic cancer	7.41e-06	6.69e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	7.4e-06	6.68e-05	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—PTGS2—pancreatic cancer	7.39e-06	6.67e-05	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—PTEN—pancreatic cancer	7.37e-06	6.66e-05	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—PIK3CB—pancreatic cancer	7.25e-06	6.55e-05	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—PTGS2—pancreatic cancer	7.19e-06	6.49e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—MYC—pancreatic cancer	7.17e-06	6.48e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—TGFB1—pancreatic cancer	7.16e-06	6.46e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	7.14e-06	6.45e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	7.14e-06	6.44e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—CD44—pancreatic cancer	7.12e-06	6.43e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—EGFR—pancreatic cancer	7.02e-06	6.34e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	7.01e-06	6.33e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—PIK3CB—pancreatic cancer	6.99e-06	6.32e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	6.97e-06	6.29e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—APOE—pancreatic cancer	6.95e-06	6.27e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	6.9e-06	6.24e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—GLP1R—pancreatic cancer	6.85e-06	6.18e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—GCG—pancreatic cancer	6.82e-06	6.16e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PIK3CD—pancreatic cancer	6.76e-06	6.11e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—DPYD—pancreatic cancer	6.74e-06	6.08e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CXCL8—pancreatic cancer	6.72e-06	6.07e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—KRAS—pancreatic cancer	6.63e-06	5.99e-05	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—AKT1—pancreatic cancer	6.62e-06	5.98e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	6.58e-06	5.94e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—APOE—pancreatic cancer	6.57e-06	5.93e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—TYMP—pancreatic cancer	6.55e-06	5.92e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—TYMS—pancreatic cancer	6.52e-06	5.89e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	6.51e-06	5.88e-05	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—PTEN—pancreatic cancer	6.44e-06	5.82e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CASP3—pancreatic cancer	6.43e-06	5.81e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—STK11—pancreatic cancer	6.41e-06	5.79e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—SLC2A2—pancreatic cancer	6.39e-06	5.77e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—TYMS—pancreatic cancer	6.37e-06	5.75e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—CD44—pancreatic cancer	6.35e-06	5.74e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	6.32e-06	5.71e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PIK3CG—pancreatic cancer	6.27e-06	5.66e-05	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—PTEN—pancreatic cancer	6.27e-06	5.66e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CCND1—pancreatic cancer	6.26e-06	5.65e-05	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—PIK3CA—pancreatic cancer	6.26e-06	5.65e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	6.22e-06	5.62e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CTNNB1—pancreatic cancer	6.2e-06	5.6e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	6.16e-06	5.57e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	6.1e-06	5.51e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—GCG—pancreatic cancer	6.09e-06	5.5e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—PIK3CA—pancreatic cancer	6.09e-06	5.5e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—MMP9—pancreatic cancer	6.08e-06	5.49e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PPARG—pancreatic cancer	6.05e-06	5.46e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—PTEN—pancreatic cancer	6.04e-06	5.46e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	6.02e-06	5.44e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PIK3CG—pancreatic cancer	5.93e-06	5.35e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PIK3CB—pancreatic cancer	5.89e-06	5.32e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PTGS2—pancreatic cancer	5.84e-06	5.27e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—CD44—pancreatic cancer	5.79e-06	5.23e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—STK11—pancreatic cancer	5.73e-06	5.17e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PPARG—pancreatic cancer	5.72e-06	5.17e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	5.67e-06	5.12e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—HRAS—pancreatic cancer	5.63e-06	5.09e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	5.62e-06	5.07e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—SRC—pancreatic cancer	5.61e-06	5.06e-05	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—PIK3CA—pancreatic cancer	5.58e-06	5.03e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	5.56e-06	5.02e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—GCG—pancreatic cancer	5.55e-06	5.01e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—TYMS—pancreatic cancer	5.52e-06	4.98e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PIK3CD—pancreatic cancer	5.51e-06	4.98e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—VEGFA—pancreatic cancer	5.46e-06	4.93e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—STAT3—pancreatic cancer	5.41e-06	4.88e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—NRAS—pancreatic cancer	5.39e-06	4.87e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	5.37e-06	4.85e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—AKT1—pancreatic cancer	5.36e-06	4.84e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—APOE—pancreatic cancer	5.3e-06	4.79e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—GLP1R—pancreatic cancer	5.28e-06	4.77e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—STK11—pancreatic cancer	5.22e-06	4.71e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PIK3CD—pancreatic cancer	5.21e-06	4.71e-05	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—PIK3CA—pancreatic cancer	5.2e-06	4.7e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—DPYD—pancreatic cancer	5.2e-06	4.69e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—APOE—pancreatic cancer	5.18e-06	4.68e-05	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—AKT1—pancreatic cancer	5.11e-06	4.61e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PTEN—pancreatic cancer	5.09e-06	4.6e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—MYC—pancreatic cancer	5.02e-06	4.54e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—TGFB1—pancreatic cancer	5.01e-06	4.52e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—AKT1—pancreatic cancer	4.97e-06	4.49e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—CD44—pancreatic cancer	4.95e-06	4.47e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	4.93e-06	4.45e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—TYMS—pancreatic cancer	4.93e-06	4.45e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—EGFR—pancreatic cancer	4.91e-06	4.44e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	4.9e-06	4.43e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	4.85e-06	4.38e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PIK3CB—pancreatic cancer	4.8e-06	4.34e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	4.8e-06	4.34e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PIK3CG—pancreatic cancer	4.78e-06	4.32e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PTGS2—pancreatic cancer	4.76e-06	4.3e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—GCG—pancreatic cancer	4.75e-06	4.29e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PIK3CG—pancreatic cancer	4.68e-06	4.22e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—KRAS—pancreatic cancer	4.64e-06	4.19e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PPARG—pancreatic cancer	4.62e-06	4.17e-05	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—AKT1—pancreatic cancer	4.55e-06	4.11e-05	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—PIK3CA—pancreatic cancer	4.55e-06	4.1e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PIK3CB—pancreatic cancer	4.54e-06	4.1e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PPARG—pancreatic cancer	4.51e-06	4.08e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PTGS2—pancreatic cancer	4.5e-06	4.07e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—TYMS—pancreatic cancer	4.49e-06	4.06e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—APOE—pancreatic cancer	4.49e-06	4.05e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—STK11—pancreatic cancer	4.46e-06	4.03e-05	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—PIK3CA—pancreatic cancer	4.42e-06	3.99e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—PIK3CA—pancreatic cancer	4.26e-06	3.85e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.25e-06	3.84e-05	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—AKT1—pancreatic cancer	4.25e-06	3.84e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PIK3CD—pancreatic cancer	4.21e-06	3.8e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	4.19e-06	3.78e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PTEN—pancreatic cancer	4.15e-06	3.75e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—TP53—pancreatic cancer	4.13e-06	3.73e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PIK3CD—pancreatic cancer	4.11e-06	3.71e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PIK3CG—pancreatic cancer	4.05e-06	3.66e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—APOE—pancreatic cancer	4.01e-06	3.62e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—HRAS—pancreatic cancer	3.95e-06	3.56e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PTEN—pancreatic cancer	3.93e-06	3.55e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PPARG—pancreatic cancer	3.91e-06	3.53e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—TYMS—pancreatic cancer	3.84e-06	3.47e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CD44—pancreatic cancer	3.82e-06	3.45e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.79e-06	3.42e-05	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—AKT1—pancreatic cancer	3.71e-06	3.35e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PIK3CB—pancreatic cancer	3.67e-06	3.31e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—GCG—pancreatic cancer	3.66e-06	3.31e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—APOE—pancreatic cancer	3.65e-06	3.3e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PTGS2—pancreatic cancer	3.63e-06	3.28e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PIK3CG—pancreatic cancer	3.62e-06	3.26e-05	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—AKT1—pancreatic cancer	3.61e-06	3.26e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PIK3CA—pancreatic cancer	3.59e-06	3.24e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PIK3CB—pancreatic cancer	3.58e-06	3.24e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PIK3CD—pancreatic cancer	3.56e-06	3.22e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PTGS2—pancreatic cancer	3.55e-06	3.21e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PPARG—pancreatic cancer	3.49e-06	3.15e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—AKT1—pancreatic cancer	3.48e-06	3.15e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.46e-06	3.12e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—STK11—pancreatic cancer	3.44e-06	3.11e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	3.3e-06	2.98e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PPARG—pancreatic cancer	3.18e-06	2.87e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	3.18e-06	2.87e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PTEN—pancreatic cancer	3.17e-06	2.86e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—APOE—pancreatic cancer	3.12e-06	2.82e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PIK3CB—pancreatic cancer	3.1e-06	2.8e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PTEN—pancreatic cancer	3.1e-06	2.8e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PTGS2—pancreatic cancer	3.08e-06	2.78e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—TYMS—pancreatic cancer	2.96e-06	2.67e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.95e-06	2.67e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—AKT1—pancreatic cancer	2.94e-06	2.65e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PIK3CA—pancreatic cancer	2.93e-06	2.64e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	2.9e-06	2.62e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	2.82e-06	2.54e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	2.77e-06	2.5e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PIK3CA—pancreatic cancer	2.77e-06	2.5e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PTGS2—pancreatic cancer	2.74e-06	2.48e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PPARG—pancreatic cancer	2.72e-06	2.46e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PTEN—pancreatic cancer	2.68e-06	2.42e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	2.53e-06	2.28e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PTGS2—pancreatic cancer	2.5e-06	2.26e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	2.48e-06	2.24e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—APOE—pancreatic cancer	2.41e-06	2.18e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PTEN—pancreatic cancer	2.39e-06	2.16e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—AKT1—pancreatic cancer	2.39e-06	2.16e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—AKT1—pancreatic cancer	2.26e-06	2.04e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PIK3CA—pancreatic cancer	2.23e-06	2.02e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PIK3CA—pancreatic cancer	2.18e-06	1.97e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PTEN—pancreatic cancer	2.18e-06	1.97e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	2.17e-06	1.96e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	2.16e-06	1.95e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PTGS2—pancreatic cancer	2.14e-06	1.93e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PPARG—pancreatic cancer	2.1e-06	1.89e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	1.91e-06	1.73e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PIK3CA—pancreatic cancer	1.89e-06	1.71e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PTEN—pancreatic cancer	1.87e-06	1.68e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—AKT1—pancreatic cancer	1.83e-06	1.65e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—AKT1—pancreatic cancer	1.78e-06	1.61e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	1.69e-06	1.52e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	1.67e-06	1.5e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PTGS2—pancreatic cancer	1.65e-06	1.49e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—AKT1—pancreatic cancer	1.55e-06	1.4e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	1.54e-06	1.39e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PTEN—pancreatic cancer	1.44e-06	1.3e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—AKT1—pancreatic cancer	1.38e-06	1.25e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	1.32e-06	1.19e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—AKT1—pancreatic cancer	1.26e-06	1.14e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—AKT1—pancreatic cancer	1.07e-06	9.71e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	1.02e-06	9.17e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—AKT1—pancreatic cancer	8.3e-07	7.49e-06	CbGpPWpGaD
